| dc.contributor.author |
Bollier, David |
|
| dc.date.accessioned |
2012-06-13T17:56:08Z |
|
| dc.date.available |
2012-06-13T17:56:08Z |
|
| dc.date.issued |
2005 |
en_US |
| dc.identifier.uri |
https://hdl.handle.net/10535/7976 |
|
| dc.description.abstract |
"If the goal of this conference is how to harness public benefit from biotechnological innovation, I would like to talk about the importance of the commons as a complement to the marketplace. We can learn some important lessons from the way that commons and markets interact in domains as diverse as science, the Internet, music, the visual arts, and even fashion. The theme I wish to develop is that the commons is a source of innovation and value in its own right, and can be a potent force in spurring public benefits from biotechnological research." |
en_US |
| dc.language |
English |
en_US |
| dc.subject |
biotechnology |
en_US |
| dc.subject |
innovation |
en_US |
| dc.subject |
science |
en_US |
| dc.subject |
markets |
en_US |
| dc.title |
Leveraging Scientific Commons to Foster Innovation, Access and Affordability |
en_US |
| dc.type |
Conference Paper |
en_US |
| dc.type.published |
unpublished |
en_US |
| dc.type.methodology |
Case Study |
en_US |
| dc.subject.sector |
Information & Knowledge |
en_US |
| dc.subject.sector |
New Commons |
en_US |
| dc.identifier.citationconference |
Biotechnology and Intellectual Property: Restructuring for the Public Benefit |
en_US |
| dc.identifier.citationconfdates |
September 25 |
en_US |
| dc.identifier.citationconfloc |
Montreal, Quebec |
en_US |